LA
MEDP icon

Lindenwold Advisors’s Medpace MEDP Stock Holding History

Lindenwold Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$767K Sell
1,491
-414
-22% -$181K 0.36% 58
2025
Q2 		$598K Sell
1,905
-2
-0.1% -$600 0.31% 60
2025
Q1 		$581K Sell
1,907
-47
-2% -$15.8K 0.32% 60
2024
Q4 		$649K Sell
1,954
-72
-4% -$24.4K 0.35% 58
2024
Q3 		$676K Buy
2,026
+32
+2% +$12.2K 0.34% 57
2024
Q2 		$821K Sell
1,994
-52
-3% -$20.6K 0.44% 55
2024
Q1 		$827K Sell
2,046
-7
-0.3% -$2.46K 0.44% 53
2023
Q4 		$629K Sell
2,053
-17
-0.8% -$4.59K 0.36% 58
2023
Q3 		$501K Buy
2,070
+12
+0.6% +$3.07K 0.31% 58
2023
Q2 		$494K Sell
2,058
-484
-19% -$101K 0.3% 64
2023
Q1 		$478K Buy
2,542
+14
+0.6% +$2.9K 0.3% 69
2022
Q4 		$537K Sell
2,528
-279
-10% -$55.7K 0.36% 71
2022
Q3 		$441K Buy
2,807
+32
+1% +$5.11K 0.33% 72
2022
Q2 		$415K Buy
2,775
+63
+2% +$9.12K 0.3% 75
2022
Q1 		$444K Buy
2,712
+148
+6% +$24.4K 0.27% 78
2021
Q4 		$558K Buy
+2,564
New +$537K 0.33% 72

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lindenwold Advisors's MEDP Position: Q3 2025 in Review

Lindenwold Advisors reduced its Medpace (MEDP) stake by 22% in Q3 2025, selling an estimated $181K and leaving 1,491 shares worth $767K. The position accounts for 0.36% of the portfolio, ranked #58.

Lindenwold Advisors first reported a position in MEDP in Q4 2021 and has held it in 16 quarters since. The position peaked at $827K in Q1 2024. 672 funds tracked by Wall St. Rank hold MEDP as of Q3 2025.

  • Lindenwold Advisors held 1,491 shares of Medpace worth $767K as of Q3 2025.
  • Lindenwold Advisors sold 414 Medpace shares in Q3 2025, an estimated $181K.
  • Medpace made up 0.36% of Lindenwold Advisors's portfolio in Q3 2025, its #58 holding.
  • Lindenwold Advisors first reported a position in Medpace in Q4 2021 and has held it in 16 quarters since.
  • Lindenwold Advisors's Medpace position peaked at $827K in Q1 2024.
  • 672 funds tracked by Wall St. Rank held Medpace as of Q3 2025.

Based on Lindenwold Advisors's 13F filing for Q3 2025, filed 16 Dec 2025.